Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q1 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2024

Holdings of CLDX by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−15,169−100.0%	Sold out	Holders
Q1 2025	15,169	$275.3K	<0.1%	+1,142+8.1%	Added	Holders
Q4 2024	14,027	$354.5K	<0.1%	+14,027	New	Holders